Phibro Animal Health (PAHC) Tops Q3 EPS by 5c; Guides FY15 EPS Above Expectations

Go back to Phibro Animal Health (PAHC) Tops Q3 EPS by 5c; Guides FY15 EPS Above Expectations

Cantor Fitzgerald Raises Price Target on Phibro Animal Health (PAHC) Based on Growth Prospects

May 13, 2015 12:14 PM EDT

Cantor Fitzgerald reiterates its Buy rating on Phibro Animal Health Corp. (Nasdaq: PAHC), and raised the price target to $42.00 (from $36.00), based on growth prospects.

Notably, on Tuesday night, Phibro Animal management updated its FY15 guidance, which is now revenue of $749 - $754M in revenue (from $739 - $759M), adjusted EBITDA of $109 - $110M in adjusted EBITDA (from $103 -... More

Guggenheim Remains Positive on Phibro Animal Health (PAHC), Raises Price Target to $40

May 12, 2015 11:34 AM EDT

Guggenheim maintains a Buy rating on Phibro Animal Health Corp. (NASDAQ: PAHC), and raised the price target to $40.00 (from $35.00), following F3Q15 beat. PAHC reported an adjusted diluted EPS of $0.41 ($0.05 higher than consensus and $0.07 better than Guggenheim estimate). PAHC management raised the '15 EPS guidance from... More

Phibro Animal Health (PAHC) Declares $0.10 Quarterly Dividend; 1.2% Yield

May 11, 2015 4:52 PM EDT

Phibro Animal Health (NASDAQ: PAHC) declared a quarterly dividend of $0.10 per share, or $0.4 annualized.

The dividend will be payable on June 24, 2015, to stockholders of record on June 3, 2015, with an ex-dividend date of June 1, 2015.

The annual yield on the dividend is 1.2... More